Association between prostate-specific antigen screening and prostate cancer mortality among non-Hispanic Black and non-Hispanic White US veterans
Importance Black men have higher prostate cancer incidence and mortality than non-
Hispanic White men. However, Black men have been underrepresented in clinical trials of …
Hispanic White men. However, Black men have been underrepresented in clinical trials of …
Racial differences in prostate-specific antigen–based prostate cancer screening: State-by-state and region-by-region analyses
Objective Black men are more prone to harbor prostate cancer. They are more likely to
succumb to this tumor than their White counterparts and may benefit from early detection …
succumb to this tumor than their White counterparts and may benefit from early detection …
[HTML][HTML] Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
Background In 2012, the United States Preventive Services Task Force (USPSTF)
recommended against prostate-specific antigen (PSA) screening, despite evidence that …
recommended against prostate-specific antigen (PSA) screening, despite evidence that …
Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer
Importance Prostate-specific antigen (PSA) screening for prostate cancer is controversial but
may be associated with benefit for certain high-risk groups. Objectives To evaluate …
may be associated with benefit for certain high-risk groups. Objectives To evaluate …
Evaluating prostate-specific antigen screening for young African American men with cancer
Background Despite higher risks associated with prostate cancer, young African American
men are poorly represented in prostate-specific antigen (PSA) trials, which limits proper …
men are poorly represented in prostate-specific antigen (PSA) trials, which limits proper …
Prostate Cancer Foundation screening guidelines for Black men in the United States
Abstract Background In the United States, Black men are at highest risk for being diagnosed
with and dying from prostate cancer. Given this disparity, we examined relevant data to …
with and dying from prostate cancer. Given this disparity, we examined relevant data to …
A population‐based survey of prostate‐specific antigen testing among California men at higher risk for prostate carcinoma
BACKGROUND Despite the lack of evidence demonstrating a survival benefit from prostate‐
specific antigen (PSA) screening, its use has become widespread, organizations have …
specific antigen (PSA) screening, its use has become widespread, organizations have …
Use of the prostate-specific antigen test among US men: findings from the 2005 National Health Interview Survey
LE Ross, Z Berkowitz, DU Ekwueme - Cancer Epidemiology Biomarkers & …, 2008 - AACR
Background: Although evidence that prostate cancer deaths are reduced by screening for
elevated prostate-specific antigen (PSA) concentration coupled with early diagnosis and …
elevated prostate-specific antigen (PSA) concentration coupled with early diagnosis and …
Changes in prostate-specific antigen testing relative to the revised US Preventive Services Task Force recommendation on prostate cancer screening
Importance In April 2017, the US Preventive Services Task Force (USPSTF) published a
draft guideline that reversed its 2012 guidance advising against prostate-specific antigen …
draft guideline that reversed its 2012 guidance advising against prostate-specific antigen …
Abrogation of survival disparity between Black and White individuals after the USPSTF′ s 2012 prostate‐specific antigen–based prostate cancer screening …
Background In May 2012, the US Preventive Services Task Force (USPSTF) recommended
against prostate‐specific antigen (PSA)–based screening for prostate cancer (PCa) …
against prostate‐specific antigen (PSA)–based screening for prostate cancer (PCa) …